Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Jump to section
- Article
- Challenge: Variable definition and reporting of serious adverse events
- Challenge: Interpretation of serious adverse events in light of the natural history of critical illness
- Challenge: Attribution of serious adverse events to the drug being tested
- Challenge: Attribution of death to serious adverse events
- Challenge: Interpretation of serious adverse events by research ethics boards
- Discussion
- Footnotes
- REFERENCES
- Figures & Tables
- Responses
- Metrics
Related Articles
Cited By...
- Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial
- Protocol for a multicentre prehospital randomised controlled trial investigating tranexamic acid in severe trauma: the PATCH-Trauma trial
- Optimal VAsopressor TitraTION in patients 65 years and older (OVATION-65): protocol and statistical analysis plan for a randomised clinical trial
- Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo-controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT)
- Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial
- Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT
- Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study
- Corticosteroid therapy in acute respiratory distress syndrome
More in this TOC Section
Similar Articles
